Similarly, breast cancer cell lines were transfected with a version of FAP that had low enzymatic activity exhibited faster tumor growth in vivo and faster degradation of the extracellular matrix (vs. untransfected cell lines) (33). This evidence concerns the gene FAP and breast carcinoma.